Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks about deals, orders, contracts, projects, customers, sites, or programs. We need to see if management conveys that the individual size of what it lands now is bigger than before for the same offering. Looking at the transcript, management discusses growth vectors: private brands, off-mall stores, marketplace, luxury, personalization. They talk about scaling, but do they mention that each new instance is larger? For example, off-mall stores: they have 8 Market by Macy's and 2 Bloomie's. They plan to open more. But do they say that new stores are individually larger or more productive? They mention that the ones open over a year had sales increases, but not that new ones are bigger. They talk about marketplace adding brands, but that's more volume. They talk about luxury, but not about larger deals. The question specifically asks about "successive engagements of the same kind" coming in at "progressively larger size". For example, if they say that new stores are performing better or are larger in scope, that would count. But they don't seem to say that. They talk about opening more stores, but not that each new store is bigger. They talk about adding more brands to marketplace, but that's more units, not larger size per engagement. They also mention that they are evaluating the right number and mix of locations, but no mention of increasing size per location. They talk about private brands reimagination, but that's about product lines, not about deals. They talk about personalized offers, but that's about communication. No mention of contracts or deals. Thus, the answer is NO. They are not describing that each new instance is larger; they are describing scaling up the number of instances or expanding categories, but not that the unit size is escalating. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.